Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Clinical trial NCT01748747 · COMPLETED

Trial details

NCT number: NCT01748747
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Recurrent Melanoma Stage IIA Melanoma Stage IIB Melanoma Stage IIC Melanoma Stage IIIA Melanoma Stage IIIB Melanoma Stage IIIC Melanoma Stage IV Melanoma

Start date: 2012-10-01
Primary completion: 2014-12-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.